BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 11464884)

  • 1. Molecular cytogenetic definition of 17q translocation breakpoints in neuroblastoma.
    Lastowska M; Van Roy N; Bown N; Speleman F; Roberts P; Lunec J; Strachan T; Pearson AD; Jackson MS
    Med Pediatr Oncol; 2001 Jan; 36(1):20-3. PubMed ID: 11464884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular cytogenetic delineation of 17q translocation breakpoints in neuroblastoma cell lines.
    Lastowska M; Van Roy N; Bown N; Speleman F; Lunec J; Strachan T; Pearson AD; Jackson MS
    Genes Chromosomes Cancer; 1998 Oct; 23(2):116-22. PubMed ID: 9739014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breakpoint position on 17q identifies the most aggressive neuroblastoma tumors.
    Łastowska M; Cotterill S; Bown N; Cullinane C; Variend S; Lunec J; Strachan T; Pearson AD; Jackson MS
    Genes Chromosomes Cancer; 2002 Aug; 34(4):428-36. PubMed ID: 12112532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promiscuous translocations of chromosome arm 17q in human neuroblastomas.
    Lastowska M; Roberts P; Pearson AD; Lewis I; Wolstenholme J; Bown N
    Genes Chromosomes Cancer; 1997 Jul; 19(3):143-9. PubMed ID: 9218994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of 1;17 translocation breakpoints in neuroblastoma: implications for mapping of neuroblastoma genes.
    Van Roy N; Laureys G; Van Gele M; Opdenakker G; Miura R; van der Drift P; Chan A; Versteeg R; Speleman F
    Eur J Cancer; 1997 Oct; 33(12):1974-8. PubMed ID: 9516836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stepwise occurrence of a complex unbalanced translocation in neuroblastoma leading to insertion of a telomere sequence and late chromosome 17q gain.
    Schleiermacher G; Bourdeaut F; Combaret V; Picrron G; Raynal V; Aurias A; Ribeiro A; Janoueix-Lerosey I; Delattre O
    Oncogene; 2005 May; 24(20):3377-84. PubMed ID: 15735707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular cytogenetic analysis of recurrent unbalanced t(11;17) in neuroblastoma.
    Stallings RL; Carty P; McArdle L; Mullarkey M; McDermott M; Breatnach F; O'Meara A
    Cancer Genet Cytogenet; 2004 Oct; 154(1):44-51. PubMed ID: 15381371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Identification of the breakpoint-flanking markers on chromosomes 1 and 17 of a constitutional translocation T(1;17)(P36;Q12-21) in a patient with neuroblastoma].
    Laureys GG
    Verh K Acad Geneeskd Belg; 1995; 57(5):389-422. PubMed ID: 8571670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular cytogenetic analysis of 1;17 translocations in neuroblastoma.
    Van Roy N; Cheng NC; Laureys G; Opdenakker G; Versteeg R; Speleman F
    Eur J Cancer; 1995; 31A(4):530-5. PubMed ID: 7576960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variety and complexity of chromosome 17 translocations in neuroblastoma.
    Schleiermacher G; Raynal V; Janoueix-Lerosey I; Combaret V; Aurias A; Delattre O
    Genes Chromosomes Cancer; 2004 Feb; 39(2):143-50. PubMed ID: 14695994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gain of distal chromosome arm 17q is not associated with poor prognosis in neuroblastoma.
    Spitz R; Hero B; Ernestus K; Berthold F
    Clin Cancer Res; 2003 Oct; 9(13):4835-40. PubMed ID: 14581355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma.
    Bown N; Cotterill S; Lastowska M; O'Neill S; Pearson AD; Plantaz D; Meddeb M; Danglot G; Brinkschmidt C; Christiansen H; Laureys G; Speleman F; Nicholson J; Bernheim A; Betts DR; Vandesompele J; Van Roy N
    N Engl J Med; 1999 Jun; 340(25):1954-61. PubMed ID: 10379019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of chromosome breakpoints in neuroblastoma at sub-kilobase resolution using fine-tiling oligonucleotide array CGH.
    Selzer RR; Richmond TA; Pofahl NJ; Green RD; Eis PS; Nair P; Brothman AR; Stallings RL
    Genes Chromosomes Cancer; 2005 Nov; 44(3):305-19. PubMed ID: 16075461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Localization of the 17q breakpoint of a constitutional 1;17 translocation in a patient with neuroblastoma within a 25-kb segment located between the ACCN1 and TLK2 genes and near the distal breakpoints of two microdeletions in neurofibromatosis type 1 patients.
    Van Roy N; Vandesompele J; Berx G; Staes K; Van Gele M; De Smet E; De Paepe A; Laureys G; van der Drift P; Versteeg R; Van Roy F; Speleman F
    Genes Chromosomes Cancer; 2002 Oct; 35(2):113-20. PubMed ID: 12203774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Constitutional translocation t(1;17)(p36.31-p36.13;q11.2-q12.1) in a neuroblastoma patient. Establishment of somatic cell hybrids and identification of PND/A12M2 on chromosome 1 and NF1/SCYA7 on chromosome 17 as breakpoint flanking single copy markers.
    Laureys G; Speleman F; Versteeg R; van der Drift P; Chan A; Leroy J; Francke U; Opdenakker G; Van Roy N
    Oncogene; 1995 Mar; 10(6):1087-93. PubMed ID: 7700633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 17q gain in neuroblastoma predicts adverse clinical outcome. U.K. Cancer Cytogenetics Group and the U.K. Children's Cancer Study Group.
    Bown N; Lastowska M; Cotterill S; O'Neill S; Ellershaw C; Roberts P; Lewis I; Pearson AD;
    Med Pediatr Oncol; 2001 Jan; 36(1):14-9. PubMed ID: 11464868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The neuroblastoma, "enfant terrible" among pediatric tumors].
    Laureys G
    Verh K Acad Geneeskd Belg; 2003; 65(1):5-23; discussion 23-8. PubMed ID: 12802894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The N-myc and c-myc downstream pathways include the chromosome 17q genes nm23-H1 and nm23-H2.
    Godfried MB; Veenstra M; v Sluis P; Boon K; v Asperen R; Hermus MC; v Schaik BD; Voûte TP; Schwab M; Versteeg R; Caron HN
    Oncogene; 2002 Mar; 21(13):2097-101. PubMed ID: 11960382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing histopathological classification with MYCN, 1p36 and 17q status detected by fluorescence in situ hybridisation from 14 untreated primary neuroblastomas in Singapore.
    Yong MH; Hwang WS; Knight LA; Fung W; Chan MY; Seow WT; Chui CH
    Singapore Med J; 2009 Nov; 50(11):1090-4. PubMed ID: 19960166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MYCN amplification and 17q in neuroblastoma: evidence for structural association.
    O'Neill S; Ekstrom L; Lastowska M; Roberts P; Brodeur GM; Kees UR; Schwab M; Bown N
    Genes Chromosomes Cancer; 2001 Jan; 30(1):87-90. PubMed ID: 11107180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.